Invited review: Vascular and other non-tumour applications of photodynamic therapy

Lasers in Medical Science

Volumn 11, Issue 1, 1996, Pages 3-10

  Nyamekye, I ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Aminolaevulinic acid; Arteries; Fibrocellular intimal hyperplasia; Non tumour; Photodynamic therapy; Phthalocyanine

Indexed keywords

PHOTOSENSITIZING AGENT; PHTHALOCYANINE;

ANGIOPLASTY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; CANCER THERAPY; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0029843057     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02161287     Document Type: Article

References (63)

1. Finsen NR. Phototherapy. London, 1901
2. Jesionek A, von Tappeiner H. Zur behandlung der Hautcarcinome mit fluorescierenden stoffen. Arch Klin Med 1905, 82:223-7
3. Lipson RL, Blades EJ. The photodynamic properties of a particular hematoporphyrin-derivative. Arch Dermatol 1960, 82:508-16
4. Edwards L, Gouterman M. Porphyrins XV. Vapor absorption spectra and stability: phthalocyanines. J Mol Spect 1970, 33:293-310
5. Frigerio NA. Metal phthalocyanines. US Patent No. 3,027,391
6. Wrenn Jr FR, Good ML, Handler P. The use of positron-emitting radioisotopes for the localization of brain tumours. Science 1951, 113:525-7
7. Spikes JD. Phthalocyanines as photosensitizers in biological systems and for photodynamic therapy of tumours. Photochem Photobiol 1986, 43:691-700
8. Rosenthal I. Yearly review. Phthalocyanines as photodynamic sensitizers. Photochem Photobiol 1991, 53:859-70
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol (B: Biology) 1990, 6:143-8
10. Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990, 136:891-7
11. Loh CS, Bedwell J, MacRobert AJ et al. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 1992, 66:452-62
12. Foote CS. Mechanisms of photosensitized oxidation. Science 1968, 162:963-70
13. Kohn K, Kessel D. On the mode of cytotoxic action of photoactivated porphyrins. Biochem Pharmac 1979, 28:2465-70
14. Robinson RS, Roberts AJ, Campbell ID. Photooxidation on b-hydrobutyrate dehydrogenase: studies of membrane fragments and intact mitochondria Photochem Photobiol 1987, 45:231-4
15. Ben-Hur E, Miller H, Miller B, Rosenthal I. Photodynamic therapy of age-related macular degeneration and atherosclerosis. Ber Bunsenges Phys Chem 1989, 93:279-84
16. Moan JK, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991, 53:549-53
17. Wilson BC. Photodynamic therapy: light delivery and dosage for second-generation photosensitizers. In: Bock G, Harnett S (eds) Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use. Chichester: Ciba Foundation Symposium 146, 1989:60-77
18. McCubbin I, Phillips D. The photophysics and photostability of zinc and aluminium sulphonated napthalocyanines. J Photochem 1986, 34:187-95
19. Diamond I, McDonagh AF, Wilson CB et al. Photodynamic therapy of malignant tumours. Lancet 1972, 2:1175-7
20. Dougherty TJ. Photodynamic therapy. In: Jori G, Perria C (Eds) Photodynamic Therapy of Tumors and Other Diseases. Padova: Edizioni Libreria Progetto, 1985:267-79
21. Kelly JF, Snell ME. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976, 115:150-1
22. Long RG, McAfee JG, Winkelman J. Evaluation of radioactive compounds for the external detection of cerebral tumors. Cancer Res 1962, 23:98-108
23. Bohmer RM, Morstyn G. Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size. Cancer Res 1985, 45:5328-34
24. Korbelik M, Hung J, Lam S, Palcic B. The effects of low density lipoproteins on uptake of Photofrin II. Photochem Photobiol 1990, 51:191-6
25. Gluckman JL. Hematoporphyrin photodynamic therapy: Is there truly a future in head and neck oncology? Reflection on a 5-year experience. Laryngoscope 1991, 101:36-42
26. Lytle CD, Carney PG, Felten RP et al. Inactivation and mutagenesis of herpes virus by photodynamic treatment with therapeutic dyes. Photochem Photobiol 1989, 50:367-71
27. Neyndorff HC, Bartel DL, Tufaro F, Levy JG. Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion 1990, 30:485-90
28. Horowitz B, Williams B, Rywkin S et al. Inactivation of viruses in blood with aluminum phthalocyanine derivatives. Transfusion 1991, 31:102-8
29. Malik Z, Hanania J, Nitzan Y. New trends in photobiology. Bactericidal effects of photoactivated porphyrins - an alternative approach to antimicrobial drugs. J Photochem Photobiol (B: Biology) 1990, 5:281-93
30. Martinetto P, Gariglio M, Pancani I et al. Hematoporphyrin photodynamic effects "in vitro" and "in vivo" microbiological experiments after laser and daylight exposure. In: Jori G, Perria C (eds) Photodynamic Therapy of Tumours and Other Diseases. Padova: Edizioni Libreria Progetto, 1985:367-70
31. Singer CRJ, Linch DC, Bown SG et al. Differential phthalocyanine photosensitization of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation. Br J Haematol 1988, 68:417-22
32. Singer CRJ, Bown SG, Linch DC et al. Phthalocyanine photosensitization for in vitro elimination of residual acute non-lymphoblastic leukaemia: preliminary evaluation. Photochem Photobiol 1987, 46:745-9
33. Ben-Hur E, Miller H, Miller B, Rosenthal I. Photodynamic therapy of age-related macular degeneration and atherosclerosis. Ber Bunsenges Phys Chem 1989, 93:279-84
34. Rosenthal I. Yearly review. Phthalocyanines as photodynamic sensitizers. Photochem Photobiol 1991, 53:859-70
35. Manyak MJ, Nelson LM, Solomon D et al. Photodynamic therapy of rabbit endometrial transplants: a model for treatment of endometriosis. Fer Steril 1989, 52:140-5
36. McCullough JL, Weinstein GD, Douglas JL, Berns MW. Photosensitizers in dermatology. Photochem Photoblol 1987, 46:77-82
37. Spears JR, Serur J, Shropshire D, Paulin S. Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. J Clin Invest 1983, 71:395-9
38. Kessel D, Sykes E. Porphyrin accumulation by atheromatous plaques of the aorta. Photochem Photobiol 1984, 40:59-61
39. Spokojny AM, Serur JR, Skillman J, Spears JR. Uptake of hematoporphyrin derivative by atheromatous plaques: Studies in human in-vitro and rabbit in-vivo. J Am Coll Cardiol 1986, 8:1387-92
40. Litvack F, Grundfest WS, Forrester JS et al. Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits. Am J Cardiol 1985, 566:667-71
41. Prevosti LG, Wynne JJ, Becker CG et al. Laser-induced fluorescence detection of atherosclerotic plaque with hematoporphyrin derivative used as an exogenous probe. J Vasc Surg 1988, 7:500-6
42. Pollock ME, Eugene J, Hammer-Wilson, Berns MW. Photosensitization of experimental atheromas by porphyrins. J Am Coll Cardiol 1987, 9:639-46
43. Neave V, Giannotta S, Hyman S, Schneider J. Hematoporphyrin uptake in atherosclerotic plaques: therapeutic potentials. Neurosurgery 1988, 23:307-12
44. Visona A, Cuomo V, Zanetti G et al. Accumulation of Zinc-Phthalocyanine (Zn-Pc) in the aorta of atherosclerotic rabbits. Laser Med Sci 1989, 4:167-70
45. Eldar M, Yeruchalmi Y, Kessler E et al. Preferential uptake of a water-soluble phthalocyanine by atherosclerotic plaques in rabbits. Atherosclerosis 1990, 84:135-9
46. Litvack F, Grundfest WS, Forrester JS et al. Effects of hematoporphyrin derivative and photodynamic therapy on atherosclerotic rabbits. Am J Cardiol 1985, 566:667-71
47. Prevosti LG, Wynne JJ, Becker CG et al. Laser-induced fluorescence detection of atherosclerotic plaque with hematoporphyrin derivative used as an exogenous probe. J Vasc Surg 1988, 7:500-6
48. Neave V, Giannotta S, Hyman S, Schneider J. Hematoporphyrin uptake in atherosclerotic plaques: therapeutic potentials. Neurosurgery 1988, 23:307-12
49. Dartsch PC, Eschinger T, Betz E. Responses of cultured smooth muscle cells from human nonatheroscleratic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses. J Am Coll Cardiol 1990, 15:1545-50
50. Eton D, Coburn MD, Shim V et al. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. J Surg Res 1992, 53:558-62
51. Ortu P, LaMuraglia GM, Roberts G et al. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation 1992, 85:1189-96
52. Muraglia GM, Ortu P, Flotte TJ et al. Chloroaluminium sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat; Implications for photodynamic therapy. Am J Pathol 1993, 142:1898-905
53. LaMuraglia GM, ChandraSekar NR, Flotte TJ et al. Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects. J Vasc Surg 1994, 19:321-31
54. Moan JK, Peng Q, Evensen JF et al. Photosensitizing efficiencies, tumor and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 1987, 46:713-21
55. Tralau CJ, Young AR, Walker NPJ et al. Mouse skin photosensitivity with dihaematoporphyrin ether (DHE) and aluminium sulphonated phthalocyanine (ALSPc): a comparative study. Photochem Photobiol 1989, 49: 305-12
56. Nyamekye I, Buonaccorsi G, McEwan J et al. Inhibition of intimal hyperplasia in balloon injured arteries, using adjunctive photodynamic therapy. European Journal of Vascular Surgery 1996, 11: 19-28
57. Nyamekye I, Anglin S, MacRobert A et al. Photodynamic therapy of normal and balloon injured rat carotid arteries using 5-aminolaevulinic acid. Circulation 1995, 91:417-25
58. Waller BF, Pinkerton CA, Orr CM et al. Morphological observations late (>30 days) after clinically successful coronary balloon angioplasty. Circulation 1991, 83 (Suppl. I):I28-I41
59. Dick RJ, Haudenschild C, Popma JJ et al. Insights from quantitative histologic analysis of excisional atherectomy specimens. Circulation 1990, 82 (Suppl. II):III311
60. Deckelbaum LI, Scott JJ, Stetz ML et al. Photoinhibition of smooth muscle cell migration: potential therapy for restenosis. Lasers Surg Med 1993, 13:4-11
61. March KL, Patton BL, Wilensky RL, Hathaway DR. 8-Methoxypsoralen and longwave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle. Circulation 1993, 87:184-91
62. Speedy TJ, March KL, Wilensky RL et al. The combination of 8-methoxypsorelan and ultraviolet A light in vivo inhibits smooth muscle cell proliferation after angioplasty. Circulation 1993, 88 (Part 2):I81
63. Gregory KW, Buckley LA, Haw TE et al. Photochemotherapy using psoralen and UVA in a porcine model of intimal hyperplasia. Circulation 1993, 88 (Part 2):I82